{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:16:56Z","timestamp":1793143016400,"version":"4.5.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Chronic Illness"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension is the most common comorbidity in patients with cancer. We aimed to estimate the prevalence of hypertension by demographic characteristics and cancer type among hospitalized patients with cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Hospitalized cancer patients were included using 2016\u20132018 National Inpatient Sample data. The independent variable was the presence of hypertension, which was further classified as primary, secondary, and other hypertension. Patient characteristics were grouped by age, sex, race\/ethnicity, and the 12 most common cancer types. Multinomial logistic regression was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 638,670 hospitalized patients with cancer, 56.8% had hypertension. The predicted percentages of having any hypertension were higher with age, male gender, and black race. The predicted percentages of any hypertension were the highest in kidney cancer patients across all age and race\/ethnicity groups. Uterine cancer was associated with the highest percentages of primary hypertension, followed by kidney cancer. Leukemia was associated with the highest percentages of secondary hypertension, followed by non-Hodgkin lymphoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Kidney cancer patients had the highest predicted percentage of hypertension overall, while uterine cancer and leukemia had the highest percentages of primary and secondary hypertension, respectively. This study provides evidence for identifying cancer patients who need more attention for the prevention and management of hypertension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17423953231196613","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T04:11:28Z","timestamp":1692677488000},"page":"42-55","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of primary and secondary hypertension among hospitalized patients with cancer in the United States"],"prefix":"10.1177","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-0950","authenticated-orcid":false,"given":"Chanhyun","family":"Park","sequence":"first","affiliation":[{"name":"The University of Texas at Austin College of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sola","family":"Han","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin College of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn P","family":"Litten","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin College of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2684-3167","authenticated-orcid":false,"given":"Sanica","family":"Mehta","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin College of Natural Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6070-661X","authenticated-orcid":false,"given":"Boon Peng","family":"Ng","sequence":"additional","affiliation":[{"name":"University of Central Florida"},{"name":"University of Central Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"e_1_3_4_2_2","first-page":"246","article-title":"Hypertension in patients with cancer","volume":"104","author":"Souza VB","year":"2015","unstructured":"Souza VB, Silva EN, Ribeiro ML, et al. Hypertension in patients with cancer. Arq Bras Cardiol 2015; 104: 246\u2013252.","journal-title":"Arq Bras Cardiol"},{"key":"e_1_3_4_3_2","first-page":"14","article-title":"Etiology and management of hypertension in patients with cancer","volume":"7","author":"Mohammed T","year":"2021","unstructured":"Mohammed T, Singh M, Tiu JG, et al. Etiology and management of hypertension in patients with cancer. Cardiooncology 2021; 7: 14.","journal-title":"Cardiooncology"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.01.082"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-017-0857-3"},{"key":"e_1_3_4_6_2","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"71","author":"Whelton PK","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Hypertension 2018; 71: e13\u2013e115.","journal-title":"Hypertension"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020406"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45014-4"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-022-01183-8"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2018.103"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.17570"},{"key":"e_1_3_4_12_2","unstructured":"Kaiser Family Foundation (KFF). Racial disparities in cancer outcomes screening and treatment. https:\/\/www.kff.org\/racial-equity-and-health-policy\/issue-brief\/racial-disparities-in-cancer-outcomes-screening-and-treatment\/"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120827"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021650","article-title":"Association of patterns of multimorbidity with length of stay: a multinational observational study","volume":"99","author":"Aubert CE","year":"2020","unstructured":"Aubert CE, Schnipper JL, Fankhauser N, et al. Association of patterns of multimorbidity with length of stay: a multinational observational study. Medicine (Baltimore) 2020; 99: e21650.","journal-title":"Medicine (Baltimore)"},{"key":"e_1_3_4_15_2","unstructured":"HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality Rockville MD. www.hcup-us.ahrq.gov\/nisoverview.jsp (2022)."},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2022.100094"},{"key":"e_1_3_4_17_2","unstructured":"Cancer stat facts: common cancer sites. National Cancer Institute (NCI). https:\/\/seer.cancer.gov\/statfacts\/html\/common.htm (2022)."},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01049-5"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030625"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28972"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.14.1765"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2019.11.009"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02953"},{"key":"e_1_3_4_26_2","article-title":"Association between tyrosine-kinase inhibitor induced hypertension and treatment outcomes in metastatic renal cancer","volume":"3","author":"Gadd M","year":"2020","unstructured":"Gadd M, Pranavan G, Malik L. Association between tyrosine-kinase inhibitor induced hypertension and treatment outcomes in metastatic renal cancer. Cancer Rep (Hoboken) 2020; 3: e1275.","journal-title":"Cancer Rep (Hoboken)"},{"key":"e_1_3_4_27_2","first-page":"736","article-title":"Clinical analysis of endometrial cancer patients with obesity, diabetes, and hypertension","volume":"7","author":"Yin XH","year":"2014","unstructured":"Yin XH, Jia HY, Xue XR, et al. Clinical analysis of endometrial cancer patients with obesity, diabetes, and hypertension. Int J Clin Exp Med 2014; 7: 736\u2013743.","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep44808"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/03009734.2018.1473534"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3721"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2016.02.078"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2019.10.023"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq091"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw211"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318051"}],"container-title":["Chronic Illness"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17423953231196613","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17423953231196613","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17423953231196613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:01:29Z","timestamp":1777388489000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17423953231196613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1177\/17423953231196613"],"URL":"https:\/\/doi.org\/10.1177\/17423953231196613","relation":{},"ISSN":["1742-3953","1745-9206"],"issn-type":[{"value":"1742-3953","type":"print"},{"value":"1745-9206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]}}}